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_INTRODUC'l'J.ON 
In 1967, Kapl an and co-worke r s ( 1) r epor t ed ths a nti ··· 
inflammatory act:l vity of cryogeninc , an aJ.kb.J.oid obta ined 
from the 111ex i can plant Jl~lmia S§)is;j.f_Ql:i._~ Lin1< and Ot t o . 
The s tructural formula of cryoge:n1ne is ill ustra ted in 
Figul'e 1 . Ora 1 admin istration of cryogcni.ne ( 100 mg. /Kg.) 
to r ats \'las s hovm to be equipotent to phenylbutazone t n 
both acute carrageenin-- .i.nd.ucccl p~:dBl cd.ema ancl chroYt.i. c 
fLyc ol;?s;J.e t9_:c).urn- induce u polyarthriti s . ·:Chis study alr: o re·~ 
por•ted certain preliminary anti h is t am :i.nic, an t:L scro to'1in , 
and anti brad:_,·kinin i nves tip; a ti ons nsi.n~ both .itJ. ___ yi.. Y..Q 2.~1.ct 
.t rL...Y..;\.t.r._Q t es t sy::; tcmr-:. In 11)69 1 ~'roLtJcr· f:.n:'J. i1n.Lon:-; \.%) 
ut1li ?. ing the techniques of Ar:dhlS ( J ) and vnn R O fJS\HII un 
clearly de fined the qu.'ll i ta t: i ve na t urcs of \;hf: em ti l1i::; t;·~­
minic ax1d. antj.::>erotmli n acti~tit1es of c r·yogerdne on ir~ c·-· 
l aterl r::rnooth musc l e p:repara tiono . Cryogcn:itw vms a no~lcc.n:-­
pe t :U; j_ve antagonist of f urtrethonium ( rnu sc.nr:i nic ) in }··~·tt 
j e junurn , a noncompetit:ive ant agonist of hj s Laml n(; in g uinea. 
pj.g i.leum , c.U sp1ayed dua l ism in antagonism of' histamJ.ne in 
g uj_nea pi g ute rus , and demons trated a no!lSpec:i. fic: block of 
s e.roton).n in rat uterus. 
One intent of this s tudy vms to detec t and. to dcfj.ne 
any a nt:i. br-adykhlin capac ity that cryogGnine may ha.·: e us i n g 
both Jn _y_t_y o and. i_n._yi tro pharmaco1ot;ical models. 1'h8 
activity of c~yo~enine in those t est s wa s co~pared to a 
1 
/ 
.Fi g ure 1. -·- S I::; rue ture of C:eyogenine . 
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varie ty of c Jin i calJ.y-·provcn a n ti- i nfla mma t or y compounds 
as \•re l l a ::: \:o other a gents known to possess anti- i n f l a m--
ma t ory a ct .i v U .. y :i.n cer'tain ex perimentally~· induced .inflamma-
tions . Cryogenin e i.s an un us ua l anti.- i nf1a mma tory a g en t 
since it i s an a lka loid - - a l l of t he c ommonly us eel a.nU.·· 
i nfl ammat ori e s ( a s p i r l n , pheny l but a zone , i nclome chacin , etc. ) 
a r e organi c a c i d s . 
Br adykinin r esear ch unknowin p; l y began a rotmd 1941 1-1hcn 
Rocha e Si lva ( 5) i nves t i gat ed t he pos s ibl e mechanisms of 
ac tion of snal<e venoms in pPDduclng anaphyla c VLe shock . 
Thes e ea rly i n vestieati ons attempted to cor r el a te the ci r cu-
l atory and puJ.monary eff ec b .> of t h e v c-:tor.; r; w j t h U1 oso (If 
:i.r.. j c c t orl pancr eat ic tryps in . Sim i l ~:~.r p:-;.y ;..:~. oJ O{.~ ical cffe.:.: tn 
pr od.nc ed. by bo th ven om:·3 Flnd trypsin l ed. R. c-.cJ{lc:. ( ~ Si.J.va to bo ... 
li e·ve t hat at l cR.s t pa:r t of tlw a C;tJ.vi ty ct t he venor' 1 ~1 ccu1d 
be attr :i hut'.e6 to pr o t eoly tiG prope r tie s . Furt her i nveGti ·-
e;c.:t. t i ons u~~ j. n.~ bot~l 1sola t ed smooth muscle preparatiOl1!:.1 and. 
s y s t emi c blood pr essur e experiments r evea l ed striki ng r e-
s embla.nc e8 be t\·Teen those e f fe c tG proc.l t~ c ed by t r ,Yps l n and 
t he v en oms . On e promin en t and c ommon B.Gt i ·.: i. ty -vms th2. d.e·-
scn si l l zation whicl J follow ed t he ~ffects. Thi s obs erv~tion 
\IIO. S interpr~ t ed. by Rc1eha e S i l vu. as a d efin :i t e }.ncU.c.:;. t i.on 
tha l the venoms and t ryps:i n \~rr:~ re pr od.uclng the Lr Gf f ec ts 
th l'o'!.lgh t he r e l eas e of encloc enous mediators . I t 'VfC\s ·rw t 
unti l 19'{·9 that Rocha e Silva and co- i n ves tigators ( 6 ) ~'!ere 
:;;.b J. e t o e luc i da te a poss i.ble med:i. a t or , a nd th i s ac ti ve 
pr).nci ple \•Tas te r med b radykinin. Since this initial break-
through , much \vOrk h as been accompl ished on the tsolation , 
purification , synthes i s , and identifica t i on of bradykinin 
( '1 -·1 0 ) • 
I t is now generally accepted that bradyld.nin l s a l)i o-
l og;icaJ l y ac t :i. ve nona peptide rel eased from the ..911211sL·· 2 
portion of serum globulin by various g l and.ular or plasma 
proteolyt ic enzymes ( ](all ikreins) d).splaying some\'lhv. t the 
specificity of trypsin. Bradykinin is compos8d of the amino-
ao:i.d sequenc:e : AHG.PBO . PRO . GLY.PHE , SER.PRO.PHS.AHG. Among 
i t s pharmacological properties are : ( a ) the ability to con-
t r<.~.c t most i sola.tc~J smooth muscle prepa rations, but re l ax 
duce pain when ~pplied t o a blister bane , (d) cau~e hypo-
e.. bronchccon~; l:;1·icti ve effect in the f.;u:i.ne:.--:. pi.g \'lhich tltay be 
antagonized by salicylates and various other analgesic/ 
anti ·- iH1'1ar;,n~a.t.(, y•y compounds ( l l - l.l~- ) . A recent and compr e --
hdns iv8 re view of kinin systems has been a uth ored by 
Sc.ha;:.:htc-;l' ( 15) l n Vihic::1 he di. scusses some of the por.:sl.ble 
phys:l.olog ical and. patho1olical s i gnificances of -plasma 
kinin:-> . In rec.8:n t yeal'r; , mueh a t tenti m1 :r~a s hem:1 focused 
on the poosibility that bradykinin is in s ome way involved 
i1~ the inflammatory pl'Oce~s , since r e l eas e of bradykinin 
has been i mplicated in both expe rimentaLly-induced and 
patholog j_ca l ly-·gene r ated inflamma t i ons ( 1 6·~24 ). Accordl:ng 
to the Literature c t tcJ. , defining the prec i se role of any 
. " . .. ' . __... 
5 
i.nflamrnatory mediator- is qul te dU'ficul t becaus e the com-
plexity of the inflammatory process seldom a llows differ-
entiation of cause from consequence. One scheme for the 
sequence of events occuring in the inflammatory response 
is illustrated in Figure 2 . 
An interesting model inflammatory response was dc-
ve1oped by Rocha e Sil va and An toni o in 1960 ( 2.5) < 'rhey 
reported that when the posterior limb of an anesthettzed 
rat was heated in a water bath at 44-45°C for a 20 to JO 
minute period, a characteristic edema resulted. Pharmaco-
logicaJ. investigations led the authors t o conclude that 
b.~·adykinin wa s the sol e mediator responsi b1e for thln therm-
ic reaction. 'l'h e:re.f'ore , the the rmal ed.err:<:~ model wa8 eho~~en 
j_n our study as ~ possible tool for detectlng agentH ca-
pable of' preventing endogenous brad;';"Jdnin-rnetl iated. tr~nunn. . 
T'h e posslbi1 t ty that the agents tested wl gh c afford. prot·.~c -· 
tion from mi.crovascu.l<:1:i' clamage i nduced by bradykinin :vas 
also inves tigated by i ntraderrnally inject i ng brad.yldnin 
and d e tecting vascular l eakage of plasma protein-· bound 
tryparJ. blue. 
This study also included a chronic ora l - dosing study of 
cryoc:;enine in the 1'8. t which was urtd.ertaken in orlier to de-· 
t ee t any possibl e mechanism of action for er-yogenine that 
ml e:;h t be revealed by microscopic examination of soft tissuc:s 
f CJJ' drug·-induced les i ons. Particular attention was paid to 
the adrenal cortical areas atld the thymus for evidence that 
cr:;ogcnine mj ght releuse endogenous cortlcosterolds . 
6 
'? 
F'j r_::ure 2 . ·· - ft•opoGerl mechanisms of J.nf1amme tto:n ~- a 
dynarrdc proce ss i n which many reactions 
occur simultaneously, as well as sequen-
tia 11y . 
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?rotei n 2:.ysis 
co 
those d cse1'j.he:d. by Rocha e Silva n :r:tc1. /,.nl;oni0 
mo.J. c , c:-JJ. b:Lno rat e: ( 11!-0--·200 Gm . , S ilnon~-:c-:n/l.:l) 
( 
'I c• \ 
{.. ;; J • 
0 . 25;:{ agar and admi ni s t e r ed at b. dosage volume of :1. 0 :·:L / t(g: , 
using r:m o ral feeding n eedl e . Con troJ.s :r·ecei ve d vel.l.i.(d.e 
only . One h our afte r dos ing : the anima l s we~e anesthe ti zed 
wi th sodi um pe ntobar bi tal ( 45 mg . / Kg . ) ndmlniste roed intr<:t·· 
and treatGd rat s ( 8 pe r g r oup) were:. pJ.r:tC()~:: ttl '(Y~mc~. c::.r.:: ::;·:~r~~­
meter· o r a ~·mt. e r batll (L~6. 5° 0 ) such U !o.!"!:". t:ho i.Qft fo::, ·~ e ;~-
t ended into trH~ bath to a leveJ. abc·ve U1..:~ n:Jkle . '.J:b 0 bod.ie~~ 
of t he anima l s r es t.od. on a f 1.1x~ r·- t oar cl surfa ce 0.11 0. e~·'.: t cm.d.ed 
avn.~y from the bat h i n or d e r to minim:J. :3e heat.J.ng the (rn.t i:r· ~.~ 
animal. 1'he center por·L ion of t: fie f i bc r·· boa :::'d v;a:::: c ut out 
anti. r epl aced •,.r j.th heavy-me sh wi re screen i n or-d.er t o r·e-· 
.1 Obta j n ed f rom Knud o0n ' s of Lathrop, Ca l i for·n1 a and. r.· :: us ed. 
in o ur· a n.lma l q ua rte r ::; at 70-7 .5°Jt' wi th Puri na l ,Stb cb oH 
a nd vmtcr ad_l i b i tum for· at l eas t 3 to 5 days pr·i or t o 
experi ment a t ion. 
_g 
C. F . Pa l mer Co . Ltd ., Effra Roa d , Brixton , London , s. W. ? 
Eng l a nd - f·1 odel F'6 7 
9 
duce heating of the board. The ani mals ' l ef t feet we re 
placed through ?/1 6 inch holes drilled a r ound the peri-
meter of that port ion of the board just extending over 
the bath . See Figure J, After a 30-minute expos ure to 
the bath, the anj_mal s were r emoved from the apparatus and 
rectal. tempera.tures t aken approximately 5 to 10 minutes 
10 
l ater. rl'emperature determinations were made using a 
thermis t or thermometer } , the probe being inserted 6 em . r ec-
tally , One hour after r emoval from the bath, the anima ls 
v1ere sacrificed by craniovert ebral dislocat ion. ~rhe hind 
feet wer e then amputated just above the aru{le joint , and 
we i ghed t o the neares t 0 . 01 Gm . The degree of edema was 
estimated. by calculating t he pe r c en t diff1: .r ence between the 
swollen foot and the nonheated foo t of the same animal (> 
I n adc1i tion to the slngl e-·dose d.r ug studies, a multi-· 
ple- dose study \'las also undertaken where in the rats we r G3 
dosed orally once a day two days prior to exposure to the 
ther mic bath and dos ing continued f or four days after t he 
thex-rnal trauma. Foot vol umes \'.Jere r ecorded daily star•ting 
at plus one hour af t er remova l from the bat h and wer•e c1.e--
termined. ple thysmographically by immers ing each r at ' s paws 
into a mercury well up to a r efer ence mark inked on the 
ankle . Displacement of mercury in the well caused by the 
-----------------------
). Yellow Springs Instrument Co ., Inc ., Yello\'T Springs , Ohio , 
Nodel 4J'I'A. 
l:J. 
Fi gure J. -- Top vi ew of thermaJ. cdc~u apparat us . 
12 
foot was transmitted as a pr·essur e change to a Statham 
P2JBB transduce r fill ed wlth distilled water . rrhe slgnal s 
f rom the transduce r were then amplified and recorded us.i.ne 
a Beckman 1'ype RS Dynogr a ph mod.i fi ect with a r es is tor/ 
capac l tor ne t work in order to elirnlna t e bacl<gr ound n.ol s e 
present at the l evels of sensitivity necessar y for measur-
lng the small changes in vol ume . Ca l ibration of the unl t 
was carried out by introduclng into the well a milled 
aluminum rod scored at 1. 0 , 2. 0, and 3 . 0 ml. In this man-
ne r , "ml . edema " could be estimated by subtra cting the 
volwne of the nonheated foo t from that of the afflicted 
foot . 
A third lltethod of employ l :ng the ther fl':: . .l eclem9. !!';O(~.e 1 
was also i.nvBs t i gat ed wher eby animal s t'fcn·e dosed or a1 ly 
t wo day9 pr ior t o thermal trauma and a gain appr·ox j_mo. t,·;J.y 
one hour before exposure t o the bath. One hour after r e-
moval from the ba th, the animals were sacrificed , the f ee t · 
amputated and weighed as previously descr ibed. In these 
mul tipl e- dose studies , the animals were allowed f r ee access 
to food ancl water . 
] s ol_{;lj;ed_J'J!t_ ut_§)_r..JJ_§ . --- Adul t , albino , vi r gin, f emale 
rats (Si monsen/A , obtained as noted earli er ) were inj ected 
with die thyl stilbes trol (1.0 mg. / Kg. ) s ubcut aneous ly in the 
scruff of the neck 24- hours prior t o sacri fice by crania-
vertebral dislocation. The diethylstilbestrol (an estro-
gen ic agent) promotes an estrus which is essential for a 
13 
qui escent isol ated uterine preparation. Immediately a fter 
sacri ftce , a uterine horn Nas exch;ed, trinuned. of excess 
f a t and suspended in De Jalon ' s perfusat e (s ee Appendix A) 
prewarmed to 31°C , and aerated wi th 95%02/5%C02 gas mix-
t ure . The uterus was attached to a lightly loaded iso t onic 
f ront al writ i ng l eve r and a llowed to equil i brate wj t h sev-
e r al washi ngs of fresh perfusa t e for a period of one hour 
14 
pri or t o being challenged 'IJi th bradykinin ( BDK ) . See Appen·~ 
dix B f or pJ·eparation of bradykinin chal l enge solut i ons . 
~1agni fi.C. <':'l.t ior;. of r espon sr-; s r ecorded by the lever vms appr ox-
i ma t ely 18 ttrnc:s E;.nl\ excursions were recor ded on a sooted 
kymogr·c.p~·! :->').r·:·a c:() . After the equili brnt ion peri od, a series 
of h:r·ad.{kln:~ :·, \~tH:d. len~es ':!ere acl<led to the Li.-9 . 0 rnl . O'!'eaxl 
bath j_n a c tmul atlve manner- as described t~y van Rossum ( 4) . 
Table I represents the concentrations of bradykinin u~ilized 
i n t hese experiments . A step-by- step cumulation of doses 
f ollowed until maximum contraction of the tissue had been 
r eached. A waiting peri od of 1 t o 2 minut es was necessary 
be t ween each challenge f or the c ontrac t ion plateau t o occur . 
After ever y t hi rd addition of bradykini n , the per fusat e 
volume was read j usted to 1+9 . 0 ml. Maxi.mum contraction vtas 
that r esponse evoked when further addi t ions of agonist 
would not produce any i ncrease in contrac t i on hei ght over 
the previous cha llenge . Af t er r each i ng max i mum c ont racti on , 
t he ti ssue was washed appr oximately 10 times wi t h fresh , 
















Table I -- Analysis of Bradykinin Chal lenge Solutions 
Ml. Solut i on Stock Solutiont Actual Amount 
Acld.ed to Bradykinin/ml . Added to Bath 
49 . 0 ml. Bath 
1.0 5. 3 ng . 5 . 3 ng. 
0 .7 1 6 n no-- · IV C "" 11.2 ng . 
0 . 7 5) .0 ng . · 37 . 1 ng . 
0 . 7 160 . 0 ng . 112 . 0 ng. 
0 ? . ' 530 . 0 ng . 371.0 ng. 
0 . 7 1. 6 meg . 1.12 me g . 
0.7 5. 3 meg. 3.71 meg. 
0.7 16.0 meg . 11.20 meg. 
0 . 7 53 . 0 meg . 37 . 10 meg. 
0.7 160 . 0 meg . 112 . 00 meg . 
0.? 530 . 0 meg . 3?1 . 00 meg . 
Cumulative Molar 
Bath Concentration 
1 X 10- lO 
J X 10- 10 
1 X 10- 9 
3 X 10-9 
. ·o- 8 .L X .!. 
3 X 10- B 
,... 
1 x 10- r 
3 X 10- 7 
1 X 10- 6 
~ ·o- 6 ) X l 
1 X 10- 5 
!-'-
'-" 
Hith each experiment, a series of standard bradykinin 
contraction- response curves was made until consistently re-
producible r esponses were obtained, These matching curves 
were used a s pre-incubation controls, and the tissue was 
then subj ected to incubation with the lowest concentra tion 
of antae;onist . 
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In these experiments , a 1 x 10 M bath con-
centration of the test drugs was chosen as th~ lowest concen-
tration to be evaluated . Antagonist drug solutions were 
prepared so that when 1. 0 ml. of the solution. ~·Jas added to 
the 49.0 ml . bath, the desired bath molarity resulted - -
this concentration was allo\';ed to remain in contact with the 
tissue for a t en minute period before sequentia l addition of 
bradykinin wa s begun. If s ome antagoni s tic ac ~ivlty wa s de-
t ec ted with the 1 x 10- 6 M/L. concentration of the antago-
nist, then the next log series concentration t o be intro-
duced (after appropriatE; washing of the tissue) Nould be 
3 x 10-6 M/L. ( the ha lf-log step). · Otherwise, the next 
antagonist concentration would be 1 x 10-.5 f-1 /L. The highes t 
concentration of antagonis t utilized in any experiment was 
1 x 10-4 M/L. A full spectrum of bradykinin control re-
sponses (without antagonist incuba tion) v.Jas obtained bet\'Jeen 
each incuba tion with antagonis t to docwnent tissue integrity. 
This insured that all of the antagonist had been washed out 
of the tissue and tha t the tissue vrould stfll r espond to 
the bradykinin challenges as it had prior to exposure to the 
antagonist. In cases where solubilization of the antagonists 
had to be effected by additions of either acid or base , appro-
1'1 
pria te bradykinin control va lues were e s t ablished af t er 
10 minute incubations with ma tching solubil ization concen-
trations of acid. or ba se equival ent to that in the drug 
solution. Solubilization procedures and antagonis t s olut ion 
preparations are found in Appendix C toge t her with pH de t er -
minations of 1: 50 dilutions of the antagonis t i n t he per-
fusate. Whe r e pos s ible , drug dilutions were made with pe r-
fusate in orde r to minimize pH and ionic changes when added 
t o the actua l perfusing media . 
Heasur·ements wer'e made of the he :i. ght of contraction 
produced by each dose of the cumulative a gonist series. 
The se meas urement s were made from t he ba seline (res t ing 
point of the i sotonic l ever pr ior to any a·i d i toi.on of agonJ-s t ) 
to tha t point of contraction equlli bri um f' <."r t b J.t dose of' 
a gon i st . Dose-response anal yse s we r e made accordi ng t o the 
methods of Ari~ns ( 3) and van B.osswn ( 4) , a.nd appropriate 
affinity values were ca lculated . 
Vascula r :germea bili ty in rat skil} . -- Techniques em-
ployed were modified somewhat from those of previous inves-
tigators (26-29). Adult , male , albino r ats (140-160 Grn . 
Simonsen/A, source as noted before), were dos ed orally with 
the following age1';}ts 21+ hours prior to the bradyklnin-d.ye 
test and with a second dose approximately two hours prior 
to injection of trypan blue: cryogenine (100 mg./Kg .) , phenyl-
butazone (100 mg ./Kg .), flufenamic acid ( 100 mg . /Kg . ) , 
i.n<lomethacin (25 mg ./Kg.), calcium carbaspirin (200 mg./Kg .), 
hydrocortisone (50 mg ./Kg . ), and 0.25% a gar (10 ml./Kg . ) . 
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All agents were suspended or dissolved i n 0.25% agar and 
administe r ed at a dosage volume of 10 ml./Kg. At approx i·~ 
mate l y - 15 minutes , the animals were anesthetized with 
sodium pentobarbital (4.5 mg ./Kg .) injected intruperitone-· 
ally a t a dosage volume of 5 ml . /Kg . and the abdomens were 
depilated wi th electric clippers. At 0 time, the animals 
were inj ec t ed intravenously with a 1% soJ.ution of trypan 
blue in normal saline (2.0 ml ./Kg .) via the t ail vein 1 imme- -
diately followed by two bilateral intrader mal inj ections of 
5 meg . synthetic bradykinin2 (0.05 ml. vol ume , using·a. 2?G ·! 11 
hypodermic needl e ) in the shaved abdominal area . An hour 
after the bradykinin had been lnjected, the animal s were 
sacrificed by cranio-vertebra l dislocatior:.. I mmediate l y 
after- sacrifice, the abdominal sldn \~as ca J.'efully r emoved 
and inverted for examinati on and photograpi1.ic illus t ro.t ion • 
. Ql:n:Q.nic toxicity of cr::y_qg_enin~ . -·-Adult, male , albino 
rats ( \•Jistar stock , 330-·428 Gm. )~ were dosed orally each day 
with 100 mg . /Kg . cryogenine suspended i n 0. 25% agar at a 
dosage vol wne of 10 ml. /Kg . Animals receiving c r yogenine 
were housed hro per cage . Control animals were also housed 
two per cage one of which received 10 ml ./Kg . of 0.25% 
agar dai l y . Ani mals were scheduled to be sacrificed at 2 , 3, 
and L~ week intervals; but due to unavailability of the drug , 
t he study was terminated at 21 days. 
J Sandoz Pharmaceuti ca l s , BRS 640, 0.1 mg ./ml. synthetic 
bradykinin, lot 11690 55. 
4- 0btained from E. G. Steinhilber , Oshkosh , Wi scons i n , and 
f ed Puri na lab chm'l and tap water ac;l __ ~i.Q). twn . 
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At the scheduled periods of sacrifice, animals wore anes-
thetized with ether and bled by cardiac puncture . A blood 
smear· was made immediately on a glass slide and fixed in ab-
solute me thanol for two minutes followed by a ir drying. The 
rentaining blood sample was mixed. with an anticoagulant solution 
of sodium ci t rate (4.0 Gm./100 ml . disti l l ed water) -- one 
part to every 10 pa rts blood. After bleedi.ng , the anima ls 
were sacrlfieed by ether and. necropsies were performed. Speci-
mens of soft; t issues.? were excised and placed in formalin fix-· 
ative for 24 hours . After this fixation, the tissues were 
r emoved from formal in, washed in running tap water , and rough-
ly sectioned. for s ubsequent permanent f l xatlon and embedding . 
Sectioned t i ssues were placed i n sta inless s t ee l tissue cap-
sul es , r eplaced in formalin, and processed for histopa thol og-
ical examination (processing schedules and formulae a r e to be 
found in Appendices D and E). Histopathologic exami nation of 
the ti ssue spec l me:ns was conducted by Dr. Richard E, \~oJ.ke 
D.V. N., Ph .D., Dep,.-=trtment of Animal Diseases , College of Agri-
. 6 
culture, the University of Connec ticut , Stor rs , Connec ticut.-
2 Tis sues taken for examination were: col on , spleen , pan-
creas , cecum, ilewn , duodenum , j e junum , stomach , li.ver , 
kidneys, adrenals , t esticles , seminal vesic l es , prostate , 
bladder , r ec tum , trachea , t hyroid , tongue , esophagus , lungs , 
heart , thymus , ske l e t a l muscle , brain , spinal cord , aorta , 
parotid gl and , and the submandibular lyJnph node . 
6 Present address : Department of Pa thology , Universi t y of 
Rhode I s land. , Kingston, Rhode Island . 
RESUL'J.lS 
Th~r.mal_~de~9 . -- Figure J~ is representative of typical 
control r e spons es noted one hour a fter removal f r om the ther - : 
mic bath. It can be seen that thi s r elatively mild the r mal 
exposure produced a r ather severe insult to t he involved area. 
Development of' pc~techiae and sal ivation were als o noted vrhile 
heating the foot, and have been r eported by previous investi-
gators ( 2 5,29 ) . 
In our l aboratory, early pl lot studi es following the 
methods reported. by Starr and ~~est (29 ) indicated that the 
development of thermal edema was unaffected by aspirin (400 
mg ./Kg. ) Rdmtni s tered intraperitoneally or by phenylbutazone 
( 100 mg. / Kg .) via the same route of adminis t Po. tion . Both cor:1-
pow1ds vw:('e s uspended. in 0 . 25% a ga r and administered at a 
dosage volume of 5 ml. /Kg . JO minutes prior t o exposure to the 
thermic bath . One hour afte r removal from the bath , examina--
tion of t he peritoneal cavities of the aspirin-treated group 
r evealed i n ternal bleeding in all animals t es t ed , A decr ease 
in the number of petechiae and a diminution of saliva tion was 
not noted as r eported by ot her investigators (29 ) . 
The following clinically--used ant i -inflammatory agents 
were tested i n t his mode l by oral administra tion one hour 
prior to the bath: hydrocorti s one (100 mg./Kg.), calcium ca rb-
aspirin (400 mg./Kg .) , phenylbutazone ( 200 mg ./Kg.), indo-
me thacin ( 50 mg./Kg .), and flufenamic acid (200 mg ./Kg.). 
None of the se agents si gniflcrultly inhibited the formation of 
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( a ) 
- --- • I 
(b) 
Figure 4. - - Therma l edema controls ·· ·· photo t aken one 
hour after r emova l from t he thermlc bat h 
( a : dorsal , b: v entral view ). 
. ~-21. 
the edematous r e sponse . Hecalling that Rocha e Silva and 
Antonio (25 ) obtained significant inh:i.bition with chlor-
promazine (10-35 mg./Kg., administered intraperitoneally), 
22. 
a t est was conducted using 50 mg . /Kg . of this agent orally . 
'l'his dosage in our laboratory consistently had blocked. carra·~ 
geenin-incl.uced rat pedal edema ( 30). This amount of chJ.ol~pro­
mazine produced a 41% inhibition of thermal edema formation , 
and this reduction \'las statistically sieniflcant (p<0.025) . 
It was thought that the well documented ability of chlorpro-
mazine to lovrer body tempe r ature might; be involved. Con·· 
sidering this, the anti-inflammatory compounds screened earlier 
were retested with attention paid to their ef f ects on body tern -· 
perature. Table II ill us tra tt;s the :>es~.l t s c f t.hese tc ~; ts . 
As shown here, :none of the anti-infla.mi!la tory d.t't~f::=-: W<J.G effec-· 
ti ve in this t e st nor did any of the cornpottnd!:> si.gpificantly 
alter the body temperature recorded just after r emoval from the 
bath . I n the case of the last compound cited (flufenamic 
acid ), r ectal temperatures were monitor~d prior to dosing , 
plus one hour after dosing , plus 15-20 minutes after initi-
ation of thermal trauma , and after r emoval from the bath. At 
no point of determinat:i.on did the rectal temperatures differ 
s i gnificantly from the c.ontr·ols . 'l'he thermal trauma raised 
t he body temperature from an average of 37.8 to 39 . 8°C in 
control animals while on the bath . In our laborator y , carra-
geenin- induced pedal edema can be blocked in a dose- response 
manner with 160-400 mg . /Kg . of aspirin, 50-1 25 mg. / Kg . of 













Indome thacin 50 
Flufenamic Acid 200 
Effect s of Orally-Admini s t e red, Clinically- Effective 
Anti - inflammatory Agents on Thermal Edema in the Rat 
ml l ~deQ~ ~ Apparent Rec tal .t nerma. ,__ .. a. , 1o Drug p Temperatuse 
Controls 'rreated. E::ffect, % - Change, C 
. a 
82 . 82"7. 8 8o.4±5.J - 2. 8 > 0.50 - 0.11 
..l. 
90.8..:. 8 . 9 
..l. 
100 . 0..:. 5 . 3 +10 . 1 > 0 . 25 +0 . 57 
..l. 
98. 8..:.7 . 5 91. 9.!6. 7 - 7 . 0 > 0 . 50 +0.04 
97 .6.!5 . 5 81. 2:±-7 .. 0 - 16 . 8 > 0.50 +0.08 
99 .1.:9. 8 '~J 1 -t' ~ 6 \..., • - .!..l • - 16.2 > 0. 2.5 +0 . 08 
.9: Tabular fi gures r epresent the mean of 7- 8 d.etcr,r: L"Jations i' 1 S. E. 
.E 
> 0 . 50 
> 0.10 
> 0. 50 
> 0.50 
> o. 50 
l\.) 
\.,.,) 
tered orally in ugar (30 ) . 
Chlorpromazine VIas then retes t ed and tempe r ature deter-· 
ruinations were t aken . Significant inhibition of edema 
was noted again along with a signiflcant drop in body temper --
ature . 
After preliminary screening , a variety of other agents 
known to a ltor body temperature we re evalua ted in the ther-
mi c mode l . Resul ts obtained wi th chlorpromaz i ne and these 
other agen t s are summari zed in Table II I. Al l of the agents 
signifj_can t l y altered the body t empera ture and. all except 
cryogenine and r eserpine significant ly inhibited f ul l devel -
opment of the thermic re spons e. The abili ty of cryogen i ne 
to lower body t emper ature in rats -had been rlocumen t ed ·p.r:-evi-
ously by Hobichaud , _et .£!._~ . (31 ) . In our lab0r ator-y 1 or.·al 
doses of tetr abenazine (15.0-37.5 mg/Kg.) ~ l ll block ca r ra-
geenin-induced pedal edema ( 30 ). 'I'he effi cacy of tetraben-
az i ne in the thermal edema model can be seen in Figure 5 
when compared Ni th the control responses shovm in Fi gure 4 . 
I t should be noted that in t he cases of chlorpromazine , 
tet r abenazine, morphtne , and r eserpine, the dose of sodium 
pentobarb5.ta l a s the anesthet ic (normal l y 45 mg . /Kg . , tntr a-
per i t oneally) had to be ad j usted d ovmv1ard (approximately ~3/4 
of t he dose administe r ed ) in orde r to compensate for t he 
neurol ept ic act i vi ty i mpa rted by these agents . The anes-
the t i c dose di d not have t o be a l tered in the case of cryo-
genine although t hts agent has been shown to possess weak 











Table III . -- Effects of Various Orally- Administered Pharma-
cologic Agents on Thermal Edema in the Rat. 
Oral Thermal Ederr..a? % Apparent Rectal 
Dosage Drug p Temperatut;e 
mg/kg Controls Treated ,..,f"' J.. % Cha.."!J.ge, C .r:. .1. ec v, <:> 
.50 
+ .§. 
93 . 9- 7.8 
a 
.5.5.4±8.3- - 41 .0 < 0. 01 - 1 . 01 
1 .5"' ~ v 93 . 3.±-11.8 47 . 7±8.3 - 48.9 < 0.001 - 1.45 
.500 -1-100 . 0.:.9. 9 
.)_ 
71.8..:.8.2 - 28. 2 < 0.0.5 - 1.33 
500 93 . .5±7. 4 67 . 2±8 . 0 - 28.1 <0 . 0.5 +0.92 
1.5oi2 
+ . 
92 . 2- 5.7 
-1-
91 . 2..:.7.9 - 1.0 > 0.50 -0.93 
250 90 . 6±7 . 3 76.7±8.3 - 15.3 > 0.10 -0. 88 
.§. Tabular figures r epresent the mean of 7- 8 determi nations ± 1 S . E. 
b Not given as a single dose, but as 50 m~/kg dai l y for three days . 
p 
< 0. 05 
< 0.0.5 
< 0.00.5 
< 0. 001 
< 0. 025 




Fi gure 5. - - A t e trabenazine-trea t ed animal one hour after 
thermal exposure (left foo t immersion). 
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Certain pharmacologic effects of the t es t drugs were 
r eadi ly observable prior t o thermal exposure . The r eserpine 
and t e trabenaz ine anj_mals displayed near maximum palpebral 
ptosis as well as prominent hyperesthesia. The t etrabenaz ine 
group also displayed a mar ked i ncr ease in muscle tone (detec-
t ed whi l e handling the animals ) . Morphine-treated. animals 
we r e moj_erately cataJ.epttc and. over- r eactive t o touch . Benzo-
caine-treated animals were characterized by profound skin 
blanching in the extr emities . Al l of the agents in Table III 
caused a not iceabl e decrease in spontaneous motor activity . 
A time- course study of the thermal edema r esponse , it-
self , vri th plethysmographic foot vol ume determinaU.ons taken 
daily demons tra ted that the Sl·rc lling s l m·1ly decreaH~d. over' 
a pe riod of one Neek from approximatel y 100;-; over contr ols 
to a round 2016 (Figure 6 ) . The SIL1a11 hemorrhagic s po t s notice-
able durln_g development of the therma l edema evol ved into 
gene r a l ized hematomas on both top and bottom foot surfaces. 
Hi thin tN~ to three days , derrna toexf oliation \·va s pr ominent 
\'lith some feet developing external ul cer a t ion . 
Graphica l representati on of a multiple-dose study is 
also shm'.'n in Figure 6. All three of the t est drugs were ef-· 
f ect i ve in blocking full edema formation measur·ed one !·wur 
a f ter r emova l from t he bath , and t he amount of i nhibi t i on i'las 
s i gni fi cant i n a ll cases ( see Tabl e IV ). Infla mma tion i n the 
drug--treated groups r emained well be l ow contr ol l evel s duri ng 
t he entire obs e rvatio~ per iod. Figures 7- 10 demonstrate the 
gener a l appearance of the feet f ive days aft er removal from 
27 
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Fi gure 6. -- Time course study of thermal edema. 
Key : 
One hour af t e r r emoval from t he ba th 
is desi gna t ed as "0" ttme . Dosi.ng v1as 
initia t ed two days pri or to exposure to 
the bath and was te rminated on da y 3 
after removal from the bath . 
0 ·-Agar contr ol (10 mi./Kg./ctay ). 
8 - Calc1um carbasp1rin (200 mg./Kg ./day ). 
0 - Phenylbutazone (100 mg . /Kg ./da.y). 
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DAVS AFTER TriERMAL BATH 
Table IV. --. Effect of Mul tiple- Dose P~emedication 
or.. Thermall:r- I~ch~ced Pedal Edema (Vol ume). 
Test Drug Oral Dose , .9 Ther~al Edema, ~ Apparent Drug Effect, p 
(salt ) mg./Kg. % ct fO 
I 
c 
Agar 0 . 25% --- 116. 0 :t 6 . 6-
Hydrocortisone 50 77 I• + r · L· . 'i'- r • .- ')'"' ..... - I) • .) < 0 . 005 
Phenylbutazone 100 81 .7 .! 6. 7 - 29 . 6 < 0 . 005 
Ca:::-baspirin 200 90 . 7 :t 6.6 - 21 . 9 < o. 025 
(calci um ) 
§ Doses l isted had been administered once a d 2y o~ally for three consecutive days . 
Wher e salts were used, dosage is exp~essed i n ther ms of the salt form. 
b Edema -was dete :::-:nineo_ one hour after r enoval f:.~c.:': the ther mal bath . 
.£ Tabular fi gures represent the mean of 9- 12 d.e.t e r·minations :!: 1 S.E . 
\_...) 
0 
- - ----~---------· 
Fi gure 7. -~ Feet of agar control animals five days after 
r emoval from the thermal ·bath -- top and 
bottom vie\vS (two non-heated feet are shown 
beneath each se t of afflic ted feet ) . These 
fe e t are to be compa r ed to those of the drug--
treated. groups illustrated in Figures 8 , 9 , 
and 10. 
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Fig ure 8. -- l"eet of phenylbutazone - treated animals five 
days after r e moval from the thermal bath --
top and bottom vi ews (two non-heated fee t are 





Figure 9. -- Feet of hydrocorti sone-treated animals five 
days after removal from the therma l bath --
top and bottom views (two non-heated f ee t are 
shown beneath each set of 8.fflicted feet ). 
JJ 
Figure 10 ....... Feet of calciurn cB..rbaspirin treated ani mals 
five days after r emoval fr om the thermal 
bath - - top and bottom views ( two non- h eated 
t eet are shown beneath each set of afflicted 
fe e t). 
Jl-1-
the bath . 1'he drug--treat ed groups clearly d.id not have the 
degr ee of tissue damage as compared to the non--treated 
cont rol s . 
Fi gures 11-·12 demons trate the r esults of a premedication 
experiment involving a three-day ora l dose r egimen of: 0. 25% 
agar (10 ml . /K g .) , cryogcnine (100 mg./Kg. ) , i ndomethacin 
(25 mg./Kg.), and flufenamic acid (50 mr,. / Kg. ). rrhe phot o-
graphs He r e taken one hour after r emoval from t he thermic 
bath jus t a f ter \'Iei gh t de terminations had been r ecorded . Ji.e-
sults of the stat i stical ana lysis of this t est a r e shown in 
Table V. As illustrated by the photographs and Table V, 
there .is a correl ation between gene r al appear ance and inh i bi·· 
tion of thermal swelling . F'lufenarnic ac id was not effec tive 
in this test at the dosage level used. Both cryoge.nine and 
i ndornE::thac i n partially inhi bi. ted the edema-cous response and 
3.5 
f ewer petechlae developed ln t hese groups when contras ted with 
th~ a gar control group . 
I sol ated_r_at uterus . - - Fi gures 13-19 graphically illus-
trate the r esult s of the isolated uterus experiments. Phenyl-
bu tazone and calc ium carbaspirt n displa yed absolute ly no in-
hibitory acti vlty against bradykinin at any of the l eve ls of 
incubation tes ted. in thi~ system (1 x l0-6 M./L t o 1 x, l 0- 4 
M~/L). Of the remaining clinically-used anti-inflammatory 
compounds-, indomethacin wa s effective only at the highest con-
centration employed, and only noncontpetitive activity ~as 
demonstrated. Flufenamic acld demonstra ted both competitive 
and noncompetitive activity; the hi ghes t concentration re-
sembling that of dualism in competition as described by van 
Figure 11. --
( a) 
( b ) 
The rmal edema : (a ) f ee t of agar control group ; 
(b) feet of cryogenim::~treated. g:roup ( two non-· 
heated feet are shown beneath each se t of af-
flicted f ee t) . The f eet in Figure lla are to 





Figure 12. -- Therma l edema : (a) f eet of indome thacin-
treated group ; (b) f e e t of fl ufenamic acid-
treated group (two non-hea t ed .feet are shown 





Cr yogeni ne 
Indomethacin 
Fl ufenamic acid. 
Table V. - - Ef fec t of Mul tiple- Dose Pr emed i cation 
on The!'rc.al l y- Induc ed Pedal Edema (\4eight). 
Or al Dosage , 








8 7 . 1 ± 5.3-
65. 8 ± 6. 4 
56 . 0 ± 11 . 0 
0 5 1 • 9 2 / . .... - . . 
a 




+9 . 2 
a Edema determined one hour af ter removal fro!:i the thermal bath. 
b ·rabul a r figures represent the mea"l of 6- 8 <le-::;er::lina tion.s ± 1 S. E. 
p 
< 0 e 025 
< 0 . 0 25 




Figure 13. -- Rat isol ated uterus, ten minute phenyl-
butazone incubat ions followed by log-




0 - Bradykinin control curve . 
A - Represent s a mean6our ve for .incuba-tions of: 1 x 10- , 1 x 10-J , and 
1 x 1o-4 M/L. phenylbutazone. 
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. Figure 14 . -- Rat isolated uterus, ten minute calcium 
carbaspirin incubations followed by log-








0- Bradykinin control curve . . 
··4 I ~- Calcium carbaspirin 1 x 10 M L • 
r-- ~- I 
0 ro 





































Figur e 15. - - Rat isol a t ed ut e r us , t en minut e indo-
methac in i ncubatjon s followed by log-




0 -· Bradykinin control curve . 
-4 : 
~ - Indomet ha ci n 1 x 10 ' ~/L. 
Dot ted l i ne r epresen t s ten minu te 
i ncubation of 24b ~cg . NabH (1 . 0 
ml. of 0 . 02l.J·Jb NaOH' - the amount 
·equivalen t tp· t ha t used t o sol ubi-
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Figure 16 . -- Rat isolated uterus , ten minute flufen-
amic ac id tncubati ons fol l m'led by log-
concentration bradykinin challenges . 
Key: o- Bradykinin control curve . 
{),. - Fluf'enamic acj_d 1 X 10-5 M/L. 
0 ·- Flufenamic ac id 3 X . 10-J M/L . 
.. 
--
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Figure 17. -- Rat isolated uterus, ten minute cryo-
genine i ncubations followed .by log-· 










Bradykin i n control curve. 
Cryogenine 3 X 10-5 !1/L. 
Cryogenine 1 X 10-4 M/:1;.. 
Dotted line r epr esents t en minute incu-
bation of 1.0 ml . of 0.2% HOAC solution 
-- the amount equival~nt of that used 
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Figure 18. -·~ Rat isolated uterus, ten minute chlor-
promaz ine HCl incubations follo\,rec.l by lo~.­
concen tration bradykj_nin chal l enges. 
i 
Key : 
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Bradyk~nin control curve. 
Chlorpromazine 1 X 10-6 11/L. 
Chiorpromazine 3 X 10-6 I1/L. 
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t . . 
Ra t i sol ated uterus, t en minute t etra-
benazine incubat ions fol lowed by log-
concentratio·n bradykinin challenges . 
0- Bradykinin control curve . 
6 - Tetra benazine 1 x 10-4 M/ D. 
Dotted line r epresents t en minute 
incubation of 1 , 0 ml. 0 . 148% solution 
of HCl -- the amount equivalent to 
tha t used to solubilize 1 x lo-4 M/L. 
tetrabenaz i ne . 
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Ross urn ( 4 ). Cryogenine (at the tvw eff ec tive concentra tions 
t ested) demonstra t ed a mixed inhibi tory activity charac ter-
i zed by a compa r a tivel y parallel shift of the bradykini n dose-
r esponse curve to the l'ight and a consistent depre s sion of 
maximum contractility of t he tissue . Chlorpromazine demon-
strated t he most definitive type of competitive antagonism 
wjth the highes t incubation concentration displaying some non-
competitive- type act ivity. Thi s was in contras t to tetra -
benazine which demonstrated non-·competi ti ve actl vi ty and only 
at the highest incubation l evel tested. 'rabl e VI illus trates 
a quantitative evaluati on of the types of antagonism s een in 
the isolated uterus studies . 
. YaD.r~la :r _permeCl_b i li'~L_Lr.L.rat_.§kin . ~-- 'I'}l e r esults of the 
trypan blue extravasation tests are illustrated i n F.t gures 
20-23, whi ch depict typica l bra dykinin responEe~ af t er each 
drug pretreatment . Protec-tiOlL from irri t e.tion (lack of try-
pan blue vascular- exudation) is r eadily observable in t he 
case s of cryogeni ne and' hydrocorti sone , but much less so for 
calci urn carbasp:i.rin , indomethacin , flu:fenamic acid , and phenyl-
butazone . The photographs have been arranged in an order of 
decreas ing trea tment effectiveness. 
Chr_gnj.g_ toxict ty_...Qf __ Qll.Ogen:U1~ . -- At the end of the 20-
day daily dosage r egimen , the mean weight loss of the cryo-
genine group was 26 Gm . as compared to a mean weight gain of 
ll Gm . for the a gar vehicle controls , and a 42 Gm . \'Iei ght gain 
f or the non- treated controls . During this dosing pe riod , no 
evidence of a drug induced l es ion was noted in any tis s ue 
Table VI. 
Agent tested for 








Antibradykinin effects in isolated rat uterus 
(bradykinin : pD2 = 8. 5, S. D. = 0. 14) 
Bath r1olar Type of antagonism detected 
conc en t ::-at i or: Competitive : pA2 Non- compe t itive : 
- 6 1 X 10 .- none non e 
- :J 
1 X 10 · none none 
~ ::- - '+ none none - Y.. .LO 
/ 
1 ,. 10- o n one none -"- - - 5 
1 X 10_4 none :none 
1 X 10 ~one none 
1 X 10- 4- none 3 . 8 
_ c: 
5.4 1 X 10 ..; none 
3 X 10- 5 5. 9 3 . 8 
3 X 10- 5 5.3 3.7 - 4 1 X 1.0 6 . 1 3 . 7 
- 6 5. 4 1 v 10 none - .. - ' f. 
'l X 10- .; 5.9 no-:1e ..1 - -
1 X 10- ) 4 . 9 
1 X 10 - 4 none L+ . O 
a In general , incubation enhanced bradykinin respon ses by shifting dose- response curve 
to the left of c ontrol curve . 
p D .._ 
- t:. 
b Competitive antagonism by these agents >'-fO. S shc•·rr.!. t o be due in part to the sodium hydrox-
ide and acetic acid. used t;o solublize :'lut(;n::tr.:i c acid a..."'ld. cryogenine ~ res:pecti vely . 
~ -.-
, Plgure 20. --
A 
( a ) 
B 
( b ) 
Trypan blue vascular permeability test: 
(a) Bradykinin control r e sponses , (b) ve-
hicle c ontrol r e sponses aft er intradermal 
injection of 0 . 05 ml . of Sandoz bradykinin 
diluent ( see Appcncl ix B) . Blue areas .repre·-
s e11t dye extravasation and s e rve as e.n in-
dication of microvascular leakage . 
.. 
5.5 
( a ) 
.•, 
(b) 
Figure 21. - - 'l'rypan blue vascular permeability test : 
(a) r esul ts after cryogenine pretre&tment , 
100 nlg . /Kg , orally ; ( b) resul ts aft e r 
hyclroc orti·sone pr e t .r·ea tme n t , )0 mg . /~<g . 
orally. 
I 
( a ) 
:J:. l"\J ....___ ____ _ 
Figure 22. --
(b) 
Trypa n blue vascular permeability t est : 
(a ) r esults afte r calcium carbaspirin pre-
treatment , 200 mg./Kg . ora lly; (b) resul t s 










I<'i. gu.re 23. - - Trypan blue vascular per-meabi li ty test : 
(a ) r esul ts a f t er fluf enami c acid pre treat-
ment , 100 Jng ./Kg. orally; (b) results af ter 
phenylbuta zone pretreatment , 100 mg./Kg . 
ora lly . 
58 
I 
section exam.Ln ed. Some mechanical trauma produced by daily 
i:nsert j_on of the oraJ. feeding needl e Nas evident as pel 'ieso--
phagitis , with myosjtis. Adjoi:n~ng lymph node hyperpla sia 
was also s een. Typical control and cryogenine-treateo.· sec-
t ions of thymus, lymph node , adrenal cortex , and liver are 
i l luatrated in Figures 24-27. 
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I • 
( a ) 
~~ . '(' ,, .. ;~ -~·:.~· 4,t' ;, ·t-·~~:~~ ·:- t:~ ~"}·I .. ·'i~ .. • . 
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( b ) 
Figure 2l~ . ·· - Chr>onlc toxicity of cryogenine -- sections of' : 
(a ) thymus of cryogenine-treat ed animal given 
an oral close of 100 mg ./Kg . d.aily for 20 days ; 
( b) thymus of agar control , 10 ml . /Kg . daily 








Chronic toxicity of cryogenine -- sections of: 
(a) lymph node of cryogenine-treated animal 
given an oral dose of 100 mg./Kg. dally for 
20 days; (b) lymph node of agar control, 10 ml./ 




( b ) 
· Figure 26 . -- Chronic toxi city of c ryogenine -- sections of : 
(a ) adrenal of cryogeni ne-treat ed anima l given 
an ora l dose of 100 mg . /Kg , daily for 20 da ys; 
(b ) adrenal of agar control, 10 ml. / Kg. daily 




' ( b ) 
Figure ~7 . -- Chroni c toxicity of cryogenine - - section~ of : 
(a ) liver of cryogenine-treated anima l given 
100 mg . /Kg . da ily fo r 20 days ; (b) l iver of 
agar control , 10 ml . /Kg . daily for 20 days. 
l"lagnification :1.25X. 
I 
d. ".: ~:cct.c::.b:te nnt:i.~ :i.nflammatory actlvi t y against thermal edema 
\·ihei~. clir. .i eally-·establi shed anti-infl ammatory a gents we r e 
i n j f;c l.ed i.n t rnperitoneally, l.t was assumed tha t these 
agents lt{OUld also be effective lf adminis tered. orally . 1'he 
oral route is prefera~le for expe rimental work since this 
minir~d.?.es the possibiJ.i ty of counterirritat ion from the i a-
j~cti ;)11 of large doses intraperl. toneally , Non - specific :trri ·-
t at.ion hi the peritoneal cavity has been shovm to aff ec t: the 
r esults in other pharmacological models used to study em ti -
infl a:-nrna'ccr.y a c ti vi ty ( Jli-). Hos t of these phannacol og i.c 
n1 () d r: • ... ·I_ r,· ( e ·r " - -, • L • c o.rrageenin-· induced pedal ed.en1a or gntnu1 u:1:F.•. 
pouch) wi.1 J. detec t cl i..nica1ly eff e r, t i vo a:lti-:l.nflrunmr..;. t, o r.·y 
dru~s Nhel.'i they a r e aclmini ster ecl oraJ.ly. Beeause nOJ'lC nt 
t he knovm ant :l-tnfla.mmatory compounds tested i n the present 
f;tudy :·Jc~re e ffective in the sing l e -dose studies , and bceause 
they :iid. not significantly alter body temperature , i .t ~.ras 
suspected t ha t the centrally active a gents used by Rocha e 
Sll va :.1 -:-li AP.co:1io ( 25) v1ere effective mainly beeause t h e;y 
1owcr·c{1 u.,c~ :y b:')mpera.tul'e . Our subsequent investi gation ~ 
h OI-lever, fo.ilt;d. tu reveal any corre lation bctw~~en a com·-
pound 's abllity to lowe r body· temperature and its ability Lo 
i:nhi bit t h ermic edema. See Table III . 'fhe abi l ity of c e r-
tf.lin centrally··acting drugs to reduce the severi·ty or to 
slo•u· t h8 miGet . of a varic-:~ty o~ G:Xpe rimenta1ly- ind.uced. l.nr-
f l ammations has been documen t ed by others ( 3.5-39 ). The r e--
f ore , it was not s urpri s ing t ha t centrally-acting a gents 
would demonstrate pos itive r esults in t he t hermal mode l , a l -
though no a ttempt was made t o di s t i nguish be t ween t he c ent r a l 
and pe ripheral ac t ions of any cornpovr1d t es t ed . Since pento-
barbita l was us ed for anesthesia., c oncomitant a dminis trat i on 
of other neuroleptic a gen t s shoul d act t o enhRnce its de-
press i on. This syner gi s tic r e sponse could l ower systemi c and 
local blood pressure which ~auld r e s ult in l ess vascular 
l eaka ge per unl t time of exposure t o the bath . Exam.inat:i.on 
of the con t.1•ol values indica t es that pentobarbl tal a lone i s 
i ncapable of preventing t he t her mi c r e spons e . The fact that 
singl e or e l doses of known ant i -inflammator y d r ug R fnlled 
to s j gnifican t l y r educe this r el a t iv-el y nd. l cl tPauma wa ::  
thou~ht unusual - - part i cularl y since t h0 chos en dos es will 
_§_ffec;til:...e ly inhibi t ca r r ageenin- induced i n f l ammation in the 
rat ( 30 ). At thi s point , doubt was i nd ica t ed a s to the val -
idjty of t his t e st i n de t ec ting pos s ible anti- inflamm~tory 
compound.s . The academic exerci se of documenting the course 
of the the r·mic r e sponse for a week proved to be an example 
of se:rcl)d i p.i ty . It appeared tha t a s ustained body J. e.ve i of 
the ant :i.- inf l ammatory d.rugs was neces sary for the dr ugs to 
dimin ish thi s thermal r eaction . When animals were dosed 
daily for a f ew days prior to exposure to the bath and dos ·~ 
i ng continued the r eafter on a da lly basis, a remarkable 
diff e r ence bet \·feen control and treated groups was r eadily 
detecta ble (Fi gures 7- 10) . Appa r ently, · even a three- day 
"priming" dose prior to onset of thermal exposure was cap-
able of affording some protection from edema as measured one 
hour after r emoval from the bath (Figures 11-12). Although 
the activlty or cryogenine is not readily visualized. in the 
photograph (Figure 11b), an evalua tion of foot Heights 
('rable V) revealed a statistically significant 25.% inhibition 
of eo.ema. An even more dramatic inhlbi tion was seen vii.th 
indomethacin (Figure 12a). Flufenamic acid W<tas the only 
anti··inflamrnatory drug tested which was not capable of pre-
venting full development of this edematous response. In 
fact, the f ee t shown in Figure 12b appeared more swollen and 
inflammed than the controls illustrated in Figure 11a; how-
ever, the 9% in<n·ease j_n Neight over the cont r ols ( 'h\b.1 e V) 
was n ot s t atistically si.gnificant . 
If the t hermic mode l is to be employed as a tool for de-
tecting possible anti-inflammatory activity, it is suggested 
that the multi--dosing method be employed. It is j_rnportant 
to stress that oral dosing is essential since possible coun-
terirritation is minimized thus preventing false positive 
results. Moreover, most prescription anti-inflammatories 
are formulated for oral use . 
Convincing evidence vms brought forth by Hocha e Silva 
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and co-workers (25) that thermal trauma is bradykinin-mediated . 
'l'he present study neither confirmed nor di sproved this hypo-
thesis , but did tend to support it by the fact that most of 
the anti-inflammatory agents tested demonstrated low or weak 
orders of activity in the other bradykinin-Gensi tive tnod e ls 
used i n this di sserta tion. 
Thermal edema a ppears to de pend on t he r e l ea s e of some 
stor ed ti ssue principle t riggered by t he heati ng proc e ss . 
Premedication \<Ti t h anti- i nfla mmatory agents for several 
day s seems t o be n ecessary to 11 de ple t e 11 t he se stores or i n 
some tqay inhibit or limi t thi s r e l ease from the heat --expos ed 
t i ssue # 
J.n...q_lnt~d r a t uterus . - - The i solat ed orga n bath pro--
vides an excel l en t means for stud yi ng drug-recepto:r.· j_n t.er ·· 
actiOlJ S on a limi. t ed n W11be r of rec ept ors . The s j_ gmo).d. con-
centration- r esponse curve r epresents a dynamic i nte r acti on 
betvreen the drug (agoni s t ) and the tissue recept or mol e-
eules . As rn o:re ngonis t mclecu1 es are i nt.t•o(:l.UCE!d and ·r;:;~ come 
bound to r eceptor Jaol eculCJs , the biologic effect ( con~ra.u­
tion of ut8r ine mus cle i n this t es t mode l ) i s increa.:.~<:..d J.n 
a geometric f a sh :i.on . This accounts f or t he sharply l'is ing 
linear portion o f t he curve . Compl ex i nvolvements of clrug 
absorption , tran s fe r ence , and t ransport t o a distan t s ite 
of activity a r e e liminated s ince the d.r ug molecules :u .t e r-
all y bnthe the r ecept or molecules . Drugs can posses s two 
types of i nteractions with these i s olat ed r ec eptor s i tes 
these cn~e .?t:f.:..iJ1i..tY. and _j_ntx in:;> t c_aQ...ti v;L ty . 'l'he r eceptor 
and drug ):>resWllably inte r act in a molecule to molecule 
( s t oichj_ omet r ic ) manner. Rec eptors are cons idered to be 
"rea c tive« b i ol og i ca l mol ecule s l ocat ed within or on ce ll 
sur f aces , and which are ca pable of a ttracting the compli-
ment a ry 11 r·eacti V E:) 11 su~faces of the d r ug ( v.rhe the l' that drug 
. 6'1 
be a gonist or antagont st ), thu s forming a receptor-drug 
complex . This is the primary drug-receptor interaction 
known as affinity. While a drug may ha ve affini ty, the drug 
may or may not ac tivate the system to produce a response . 
I f t he drug causes a biologic r·esponse , then it is saicl to 
possess J n1 r .t ns ic aQti v_i.t,y in add.i tion to affin:i.ty . Such a 
dr·u g is t ermed an a goni s t . If n o response is produc e d, then 
only aff:i.ni ty· may be present, and the drug may ac t as an 
an tagoni [~ t . 
'J'"he p resent experiments on. isolated r at uterus demon-· 
strated tha t bra dykinin possesses an affinity of a rela-
t ively high or der (pD2 constant = 8 . 5) • · The u terus prepa r a --
tJ.on was c h or>en be cause of its g r eat s en r-.; i ti vi t;y t o b.i."ady-· 
k int n and be c ause the bradykinin induc es a contra ctton of 
thi s t. t s nue tha t c an be easily :recorded. '.rh:i.s c:ystem also 
ha-s t:-h e--ad vantage of-allowing a full r an ge of-repl ... oducible 
responses to be obtaj.ned with a minimum of expensive brady-
kinin be ing expended. The contrac tions r ecorded we re not as 
slov1 as ha.d been expectecl; most :responses peaked within. one 
minut e a fter i ntroduction of the bradykinin challenge. The 
compounds ehosen as pos s ible bradyk:i.nin antagonists for 
the s e t ests ivere s elected on the basis of their inhi bi tor·y 
activity in the thermal edema model. 
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Two c ompounds (phenylbutazone and calcium carbaspirin) 
whi ch were effective anti--edema drugs in the mul ti·-dose the:c-· 
mal e clema s tudies f a i led to d emonstrate e.ny ·anti brad.ykintn 
cu~ t:i.vity in the jsolated uterus prepnrati::nlo It can be seen 
lu f'igures 13 and 14· that the pooled effects of phenyl buta-· 
zone lnr::ubations d i d not differ from the control bradykinin 
rt:~ sr)cmse~; Hh:L l e calc i urn carbaspirin actually appeared to en-
hance the bradykinin challenges . Some controversy as to the 
true ant:i.bradykinin activi ty of these agen ts in ot her s ys -
tems J1as aris en . Simke 1 et al,. (40) has demonstrated that 
both of the se agents a r e antagonists of the bradykinin~·in·· 
ducecl bronchoconstrictive effect in the anestheti.z ed guinea 
pig . On the other hand, they are not effective bradykinin 
antagonists i h the i sol ated guinea pi g lung preparat ion as 
described by Aarsen ( 41 ) . Aa r sen ·attributes the in vivo 
antl.bradykinl.n a ctivity of pheny lbutazone and asplrin as be-
i n_g CE~Ylt:r'ally n1edtatcd sin.ce their l11 _y_t_y_q effectj~venesn vias 
r educed. by vag otomy and with the s ubs ti tu t: .ton of a barb:i. tu··· 
rat e f or urethan anesthesia , The \Wrk of Aarsen has l'.>e en 
-
challenged by Collie r , §..t_ a J.. , ( 42 ) since these- inves t-i -
gators claimed tha t such drasti c measures as spinal and brain 
pi thing failed to alter the anti bradylcinin effectiveness of 
aspir:i.n. It seems that the disposition of aspirin or phenyl-
butazone to antagonize bradyl~inin- indueed respon ses diffe r s 
in va r :i.ous test systems and i n the hands of different inves-
tlga.tors . Under these condi t ions , simple generalizations as 
to the possible mechani sms of actlon for these drugs a r e not 
pos s ible . 
Indome tha cin i n the isola ted rat uterus studies , demon-
stra ted a noncompetitive inhibition of bradykinin (Fi.gure 15 ). 
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This ac tivity was displ ayed as a depression of the maximum 
obta i nabl e hei ght of the a gonist--induced contract i ons with-
out significant shifting i n the orig :i.n of the dose-res ponse 
curve. Although some shift to the right was observed, the 
indomethacin dose-response curve was not parallel to the bra-
dykinin control curve . 'I'his departure from pa r a llelism \'tas 
another indication of the noncompetitive nature of the docu~ 
mented inhibition . The interaction of indomethacin with the 
tissue r eceptor can be said to be noncompetitive since fur-
the r addj tions of bradykinin failed to overcome the antagonis--
tic effect . Ind.omethacj_n , therefore , must be act ing on are-
ceptor surface other than that specific for· or pref erred by 
bradyk jnin. Only the highes t dose of indo:r~e t~acin e:-".1 ;-;loy E:d 
demonstr ated any ant agonistic activity. 2:.ower incubat i.on 
concentration s foll owed by bradykinin 6hal l enges very c lo3ely 
approximated control r esponses. It can a-l s-o be seen :l.n E1g-
ure 15 that the incubation of 240 meg of NaOh displayed a 
low ordef' of what appears to be competitive activity ~ersus 
bradykinin (this is seen as a parallel shift of the concen-· 
t r ation-response curve to the right along the dose axis·) . 
No depression of curve maxima was noticed in the case of NaOH 
incubation. This may be due to the property of Na+ to act 
as a membrane hyperpol arizing agent ( ti ssue stabilizer) thus 
r equiring l arger amounts of bradykinin to initiate and main-
t a in contract ! le responses . Another possibility is that the 
i ncreased ionic mileu of the pe rfusate may in some way change 
t he phys ical properties of bradykinin, thus r endering it l ess 
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reactive. Upon washing the tissue thoroughly , bradyk i nin 
control r esponses \'lere once again obtainable --· this indi-· 
cated a reversible activity. In light of the proposed NaOH 
involvement , it must be kept in mind that during the incu-
bations, only a s light excess of NaOH would be available to 
r eact with the tissue or bradykinin . Solubil i za tion was cal-
culated on a mole to mole basis s o that after solubi l ization , 
only a very small amount of Na + \<Iould not r emain in ionic 
association \<Ii th in.d.omethac i.n . The amount of NaOH in excess 
in the 1 x 10-4 M/L. indomethacin incuba tion \•Tas 40 meg . 
Because of this , the antibradykinin activity of i ndomethacin 
detec t ed i n these t ests was attributed to the drug , its elf, 
and not to t he f;olubili zi ng f actor . 
In the case of flufenamic acid , a r elatively clear com-
petitive antagonistic component was noted (Figure 16 ), al-
though at the hi ghest incubation concentra t1on some depres-
sio.n of the maximum contra.c tion did occur . The greater 
affinity constant was , however , the competitive component as . 
- 4 I noted. in 'l'able VI. Incubation of 1 x 10 N L. flufena rni c 
ac:i.d dj.d not lend itself to graphical illustration as only 
ir·regul ar and quite f eeble r esponses to bradykinin were ob-
t ained . It was decided that this concentraU.on of f'lufenamic 
acid was noriphysiol ogical for this test system . Bradykini n 
control responses were regained a ft er t horoughl y washi ng the 
t issue with fresh perfusate - - thus indi cating a r eversible 
action . I t i s f elt that t he competit i ve activity seen in 
this experiment could .be attl'i.buted to t he flufenami.c acid 
sj_nce even loss a val l able Na+ was present than i n the NaOH 
cont r ol of the indome thacin experiment . In spite of i t s 
r el atively high order of ant ibr adykinin ac t i vi ty in t he 
isolc:tf.ed v.teru::: , tt shoul d be recalled t ha t f lufenami c a c i d 
was totn1J.y without inhibi tory ac t i vi ty i n the t her mal edema 
t est s (supposedly medj_a t ed _via endogenous re l ease of brady-
kin in ). The f enama t es are potent i nhibitor s of bradykinin-
i nduced bronchocon stric t ion in the gui nea pi g a s r eported 
by Collier , .!Zt.. a l. ( 42 ) . 
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The activi t y of cryogenine in the i solated uterus i s 
shown in Fi gure 17 . Aga in , a mixed type of compe t ition was 
documentecl with the highest order of affinity be ing the c;om-
peti ti ve antagonistic comlJOnent. Some of th8 sh5.f L. -Lo the 
r i ght a long the dose- ax i s may be a ttribut ed t o the acetic 
acid used for s ol ubi l i zation , but none of the depression of 
maxi mum c ontrac tion see rned to be due to the aceti c acid . It 
should be reca lled tha t cryogen i ne posses sed onl y weak an t i -
i nf larmnator y potentia l i n the t he rmal edema . Other expe r j-
ments in our l abora tory ha ve shown cryogen i ne t o be inactive 
i n t he bradyki nin- i nduced bronchocons t r iction test (L~) ). 
Cryogeni ne was t he onl y agent tested fo r antibr adykini n pro-
per ti es whi ch di s played a low order of intrinsic activi ty. 
Cryogenine incubations caus ed some contract i on of t he ut erus 
upon i r1itia l introduc t ion , but t he ti ssue rel axed to base-
line by the t ermina ti on of t he incubation peri od (10 mi nutes ). 
The antagonis tic activities of chl or promaz i ne a gainst 
bra.dykiniil. ( F' i gure 18 ). r esembled thos e seen with cryogenine 
and fluf cnam:'Le acid. At the h1ghest incuba tion t es t ed , the 
noncompet iti ve component became qui t e obvious. In regard 
t o the r ema i ning n eurol eptic agent tested, tetra bena zine 
displ ayed only noncompetitive a ctivity a nd then only a t the 
highc.~~ t \:on0entra ti on t es t ed ( F'igure 19 ) . Earlier·, t e tra-
benaz j.ne had been shown to be very effec tive in block ing 
th8rl!1al edema . The pr oftle of activity f or t etrabenazine 
i n i s olated uterus resembled t ha t of indomethacin . The HCl 
used to solubi lize tetrabenazine d.i.d not contri bute sj.gnif-
icantly to the antagonistic activi t y recorded , 
As mentioned previously, all of the agents t es t ed as 
pos s:l bl e ru1 t agonist s of br adyldnin in the isola t ed uterus 
expe r iments were chosen becaus e of the i r ~).bi J.:i. ty to irdTi b:·L t
thermal edema . However , there \'las no cor l."e J.at ion bet~-vee:n 
the va ri ow:; ab:i.lities to block the the r ma i edema rer,.~--. ..:m se 
and the various capacities to antagonize bradykird.n-lnducC"d 
contract ions in t he isolated rat uterus . One interesting 
obs cr \·ation made from the uterine experiments Nas that three 
chemica lly unrelated compounds ( fluf enamic ac id , cryogeni.ne , 
and chlOl'promazine ) demonstrated approxima t ely the same de-
gree of eo.-npet i ti ve antagonism of brad.yldnin . According 
to the p:·w t J it:eratur e 1 most. compounds tested for antl brady-
kinin activity demonst r ate nonc ompetitive activity and are 
r ather non- specific antagonist s . Leme and Rocha e Silva 
(44i conduc t ed a serie s of tests on isol ated guinea pig il-
eum to qua lify the bradykini n an t agoni sm demonstra ted by a. 
var iety of tricyclic struc t ur0s and benzodiazcpine deriv-
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a t i ves. It was shown that onJ.y three of t he compounds 
t ested (one d i benzocyclohept ene deriva tive , and t wo th iox-
anthene derl vatives ) demonstrat ed competi tive an tagonist ic 
activ i t y a gainst the bradyki nin- induced contract i ons. 
Chl or promaz i ne wa s a nonc ompetitive ant agoni s t in thes e t es t s. 
Tht s latter f act may indicat e that i f bradykin i n r ecept ors 
do ex i st , they may be of a differ ent na ture in the guinea pig 
ileum and rat uterus . Differ ent br adykinin r ec eptor8 have 
been proposed by other s (5). In a r ecent paper, Rocha e 
Silva (4.5) di scus sed c ompetit i on in isola t ed gutnea pig ileum, 
and he expla ined tha t compounds \'lhich displa yed competitive 
ant i bra<'lykinln activity \vere r eally nonspec i f i c s i nce they 
al s o antagonized. serotonin and hi Btarnine . 'l'h J.s appea:cs t o 
be t he case 'l'li th mos t phar inacologi.c agents that bl ock auto·· 
coidsr e . g ., antihistaminics often d i spla>' anticholinergic 
effects and./or antiserotonin activity . A s earch for a c om-
pound which would specifically block on ly one agoni s t seems 
a bi t lli1real i stic in light of past a t tempts . However, the 
investigations of Rocha e Si lva and cm>Jorkers did not in-
clude an a.tt.;.mpt to define t he ant i hradykinln activity of 
kn ovm anti-inflammatory agent s ut i lizing an isolated. organ 
bath system such as presen t ed here . 
The r esult s of the present investigation are not with-
out scientific interest since two of the anti-inflammatory 
agents t ested (cryogenine and fluf enamic acid ) did demon-
str a te an ability to competitively antagonize bradykinin. 
It i s also inte r esting to note from the calculated affinity 
values that those compounds that di splayed antagonist1c ac-· 
t ivity in this study did so within a very c l ose r ange of 
molecular potency. 
Vasc_\llar P._ermeag_i Jj~y_in _rat sld.n . -- The abili ty of 
I 
bradyk.inj_n to increase microvascular permeability to c ircu-
l ating dye has been documented previous ly ( 28 ). Some work-
ers have ut ilized this t est as a possible tool f or evalu-
atlng antibradykinin activity; however , t he blocking a gents 
have often been administe red intradermally a long l'li t h the 
bradyklnin. challenge . If the response was blocked under 
such conditions , it is diff i cult to tell whether one is 
evaluating a direct chemical reaction, a local physical ef-
feet , or true drug activity . In the pr8sent study , the 
animals v1er·e dosed orally in order to avoid or minimize 
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counter.i.r·rl ta l~ion artifact::; in the evaluation . As pr.: v.i.ou~3 u· 
ly explained. , oral do sine; should ref1.ec t true drug ac-1~ i \t i ty r 
Cryogenine demons trated. a remarkable inhibition of try-
pan blue exuda tion. However , because of unavailability of 
th:is scarce drug , only one animal could be tested. Other 
photographs in Figures ?.0-23 are r epresentative of drug r e-
. 
sponses obtained in groups of three to four animals per test· 
group, ~3alicy1ates and indomethacin adJninister~d systemic-
a lly (ora lly or intravenously ) have been r eported to be ef-
f ective antagoni s ts of this bradyki nin r eaction ( 26 ) . '£he 
present study cannot support thi s conclus i on when comparing 
the 8qui vocal salicylate/in~omethacin effects to the dramatic 
inhibi t ion produced by cryogenine and hydrocortisone. How-
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ever , some protection may have been afforded s ince t he in-
tens ity of bluing seemed somewhat les s than con t rol respon-
ses. 'l'he fluf enamlc ac id- and phenylbutazone--treated gr oups 
demonstr ated a more diffuse response to dye l eakage . It is 
genera lly accepted that the mi crocirculation 11 l eaks " because 
of a retraction of the microvascular endothel.ium thus ex-· 
posine; an ex1t for fluid and some plasma. proteins . The dy e 
i s extr uded a long with the protein and provid.es an easi ly 
detec.ted 11 tag 11 for the r esponse . Agents i n l1i biting th i s 
r esponse may clo so by altering the endothelial cel l c ontrac-
ti on process and t hen the microcirculation is considered to 
be 11 protected . 11 This type of mechanism i s discussccl by 
Oyvin S'.:.L_ca.!: . (/+6 ) . This t est does not J.erct its eJ f to di::"ect 
· quaJ1titation and unl0ss very dramatic resu l ts are o'!:rtair.18d 
(such as were seen v.fith cryogeni nG and hydrocortiso:cJE:) , 
small dif f erences in drug efficacy may rema in undeteGt ed. . 
_Q.!].£Q.n i<L toxicity of cryogenin~ . -- It is the cor1s l dered. 
opinion of lhe pathol.ogi st and. pha rmacoJ.ogis t invesU.~ators 
t hat no stgntficant les ions were produced by the drug d.uring 
the 20-day dos ing period. Constant ora l dosing was not with-
out its tolJ. on the esophageal tissues , which may also ac-
count for the evident wei ght losses in the dosed groups as 
compared to t he no- dose controls . It is f elt that the cryo-
genine-treated animals lost more weight than the agar -
t reated animals because the neuroleptic activity of cryo-
genine ma y have contributed to a pos sible loss of appetite. 
It is cons idered unl ike ly that cryogenine mediates its ant i -
inflammatory effects vj2, an endoe;enous release of corti ·~ 
col.ds since i nvolution of t he thymus did n ot appear ·-·- see 
Figure 24. It can be seen in this figure that thymocytes 
predominate and that active ge rndna l cente rs are ~t i ll pre-
' 
sent. Likew i se , a comparison of l ymph node sections (F' i g-
ure 25 ) illustrates no degeneration or depl e tion of l ym·· 
phat:i.c ttssue . I n keeping \'Ti th these findings , hyperpJ.as i a 
of the ad.rena l cortex did not develop and. the corti cal t o 
merlullary rab. o remained a constant 1 : 1 ( see Pigur e 26 ). 
Total white blood cell c01mt r emained wel l wi th1.n normal 
ltmits for both treated and cont r ol groups -- the cell 
count s r anged from 12000 to 16000/ mrn3 . If cryogenine ac ted 
as a steroi d or caused tho release of cor t..: .icos t erol.cls from 
th8 adrenal s , then one would expect a de~letion of lymphoid 
ti ssue , in general, and either an enlargement (in case of 
cortica l stimulation ) or an atrophy ( in case of s teroid-
like activi ty ) of the adr enal cortex . CPyogenine was not 
hepatot oxic as shm•m in Fi gure 27. · A normal a rrangement of 
cu.boidal cell r e ticulum Hithout sinusoidal c onges tion or 
an,1,r ~ i gn of parenchymal degeneration is evident. 
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Cr'yogen 'L ne ha~; been s hO\'m to possess signif icant anti·· 
b7'·;.dyli.inj.n activi ty iu the foregoing t ests. However , 
c ryvgl~nine cannot be designa ted as a specific antagonist 
of br:-"tdykin j.n because earl ier work has shown it to pos sess 
SO!"!\(~ ;o,.nticholinc r g ic, antihistamini.c , and anti serotonin 
properties . The observation that cryogenine has some abil-
1 t~r t o antae;onL~e bradykinin competitively in the rat 
uterus preparation is inte r esting in that only one o ther 
anti-·inflammator·y compound tested ( f lufenamic acid.) shared 
tbi~ properly. Because of it s r elat ively high mol ecula r 
poteney in demo:;:1str ating a:'lt i bradykinin ac t :i.v1ty , c ·C'y(>-
I 
ge:n :i.nc 1 s ub.i li ty to act a s an anti --inf l am!tte.tory comp-nmcl 
ma;t_ l>e due in part to this :prope:r•ty . Cryog eni:nG cloes n ot 
appeal'' to release endogenous corticosteroids nor doe s j t 
appr3ar· to rJave the toxic manife stations of exogenous l y 
adr.lin i~;tered s teroids . It ~'las a l so demonstrated t l1at. t.he 
therma l edema mode l may be useful for the d e tection of 
anti ·<tnf' l .::JJJnatory a.nd/or anti bradyk:i.n.ln ac ti vi.ty pr ov:td.ed 
th E::  b.-"!s t d.r.ugs are administered ora lly ove r a. several u.ay 
period befor e the challenge . 
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APPENDIX A 
Th~ Beneral formula (47) is: 
NaCl. . . • . . . • • •. • 9 . 00 Gm . 
KCl . . . . . . . . . . . . . . 0 .42 
CaCl •. . .•.•• •.••• • 0 . 06 
NaHCOJ . • • . • . . . . • . • 0.50 
Glucose . ... . •...•.. 0.50 
D1.stilled water a , B. ad . •. 1000 .00 ml. 
Stocl{ solutions were prepared as follows: 
~~Q.l u tl on Jl.l . 
NaC l .• .• . • • • ..•• . 360.00 Gm. 
Dist j.llc(t water .Q_, B • .0.s1~ • • 2000 .00 ml. 
use 50 . 0 rnl., to prepaee 1000 rnl. p er.fusH tf.~. 
-~ o l_p t .L9.1L..i~ • 
- ---cac 12 • • • • . • • • • • 4·. 80 Grn • 
KCJ • • •••• •• •••••• 33. 60 
Distilled water g_._.§ . ad ••• 2000 . 00 rnl. 
Use 25.0 ml . to prepare 1000 ml. perfusate. 
NaHU01. . • . . • • . • • • • 10.00 Gm . 
Distl l l e1 water q,s. ad. ~ . . 500.00 rnl . 
Use 25.0 rnl . for every 1000 ml. perfusate . Thls solu-· 
U on was a lways prepared fresh , and added to well 
diluted chloride solutions. 
Solutions #1-J were stored in ground-gl a ss stoppered bottles, 
and 0 .5 Gm . glucose was added for each 1000 ml. of the fina l 
perfusate on the day of preparati on . 
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APPENDIX B 
A serieH of 11 solutions were prepa r ed in the follow-
in~ manner such that when 1. 0 ml. of any solution was 
added to the 49 . 0 ml. organ bath , the desired mol arlty 
resulted in the final 50 .0 ml . volume (see Table I) . 
Ten mg. bradykini n ( M. VI. 1060; f r om Schwarz Bio-· 
Res earch, New York , lot #v- 2075 ) was dissolved in 1 . 9 ml . 
of the diluent used. by Sandoz Pharmaceutica ls for brady-
kinin (0.5 ml. gl ac ial acet ic acid , 2.0 Gm. sodium ace-
tate , 5.0 Gm . chlorbutanol, and ? .0 Gm . sod.1.wrt ,~ (l lm.~i (le 
per l iter of aqueous solut ion) . This init i al concentra tion 
--4 I r epresented a 1 x 10 N L . bath solution. From thi s solu-· 
-5 I tion , a 1 x 10 M L . equivalent concentra tion was pr·e~ 
pared by diluting the entire 1 . 9 ml . to 20 . 0 ml . wi t h 
De Jalon 1 s perfusat e . The next equiva l ent concentra tion 
/ 
of .3 x 10- 0 l'1IL. was prepared by diluting 3. 0 mL of the 
1 x 10-5 MIL. solution to 10 . 0 ml, with perfusate . The 
r emaiJJ ing chall enges were prepared in the follm'fing man-
ner : 5. 0 wl. bradykinin solution from Sand.oz Ampul s (BRS 
640, :J..O ml . equival ent to 0 . 1 mg . synthetic bradykinin , 
l ot #69055 ) plus 4 . 4 ml . perfusate resulted in a 1 x 10-6 
MI L. fina l bath concentra tion per ml . stock . The J x 10-7 
MIL . equivalent concentra tion was prepared by us i ng 3 . 0 ml . 
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of th e 1 x 10- 6 M/L. stock solution and diluting to 10.0 ml . 
wi th perfus ate . F rom these i nit i a l log and half-log stock 
concentratl.ons , 1 : 10 serial dilutions h'ere prepared to 
comple te the . r emaining challenges i n the s e ries , J~ . ; 1 . 0 
~6 I ml. of 1 x 10 H L. equival ent s tock -~· §d 10 . 0 rol. per-
fusate r e sul ted in 10.0 ml. of 1 x 10-'1 ~1/L . stock , and 
1.0 m1. of J x 10-7 M/L. equiva l ent stock .9 ... J~ . ag 10.0 ml . 
perfusate yielded the 3 x 10-B M/L. stock cha l l enge, etc . 
as shown i n Table I . 
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APPENDIX C 
! , Flllf®amic acJ_9:_._ --( N.H. 281.21+, Parke Davis and 
li0., Det r·ott , I-Hchigan , CI -4'+0 , Lot //9422 ) 3.5 mg . plus 2.0 
ll'"t. 0 . :;;; NaOE solution .fl..§ • . ad_. 25.0 ml. dis t i lled wate r . 
D\l1Jt.:l. 1.m (.L: .50 ) of thi s initi a l stock in De Jalon's per- · 
- ~· I fus8 t e (1 X 10 M L. ) - -pH 8 . 1. 
2 , J)JS1 omcthac in,. -- ( N. 1d . .J 5'1 . 81 , Merclc, Sharp and 
Dolr•!Je He search Labs , West Poi nt, Pa . , Lot #1590226-~ 0- '?1) 
4'-.'·. '? c. " ' ) lhg <I pJuG 1.2 ml. 0 • . 5% :traOH solution .~Ld~ . g~ 25.0 ml. 
diGtille d water . Dilu~ion (1: 50) of this ini tia l slo~k in 
~-4- I Dc ... Tai.o:'1. 1o perfusate (:i. x :1. 0 H 1 .) ·--pH 8. 15. 
J . _Ph <::1J.,Y. ;I,_l~. ta Y. o:ng . ·-- ( N . H. 3 0 8 . 3? , Ge i gy Pharma-
ceutical s, Ardsley , New York , Lot SN 31 51.~2 ) 38 . 5 mg . plus 
1 ° -~ 0 ~·o-' N OH J t. d 2 5 0 1 d . t . J J d t , t. m . . . :J/o a so .u 1011 g_ • ..§. . a_ • m • 1 s 1 .. e . l'o/a ·er. 
Dilution (1 : 50 ) of this initia.l stock i n De Jalon •s perfu-
( -~~ I . ) sate 1 x 10 f'l L . - -- pH 8.3. 
l~. Cc>.:J.Qit,Jll1 _ _garb?.:,~.P.irin_,_ -- ( N .\V. ~- 58. 45, Dorsey Labs , 
Lincoln , Nebraska , Lot #44?8 ) 57.25 mg . .9...._2 . aq 25 .0 ml. 
di s t i L Led 1·1ater. Di l ution ( 1 : 50) of t h i s lni tia l stock in 
- l• 
De Jalon 1 s per f usat e (1 x 10 r M/L.) pH 8 .15. 
5. 'Petrg)?enazjne . - -· ( M. vl . 31 '? . L~1 , Hoff man- La.Roche , 
Inc. , Nut ley , N. J. , Lqt #C-421) J9.6 8 mg . plus 0 .12 ml . 
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3.7% HCl g_..__§. . §._Q, 25 . 0 ml. disti ll ed water. Dilut ion (1:.50 ) 
( - 4 of this ini t ial stock in De Jalon's perfusat e 1 x 10 
M/1.) -- pH 8 .1 5. 
' 
6 . QhlQrpromazine __ HC.J... (M.W. 3.53.9, Smith, Kline 
and French Labs , Philadelph ia , Pa., I SO # :1..5 .5544 , Lot #·166 -
7TZ) lJ-9.11 mg . HC l salt .9.....2. p.d 2.5.0 rnl. di s tilled water. 
Dilution (1: 50 ) of thi s initia l stock i n De Jalon' s per-
( -'--1· I ) f us a t e 1. x 1 0 M L • -- pH 8 • 1 • 
7 < Q:ryQgS!nil1_g . -- · ( I1 . \v . 4 3 5. 53, obtained as the alka-
loid from the Division of Pharmac ognosy, School of Pharma cy, 
The Univers ity of Connecticut, Storrs , Conn. ) 21.78 mg . 
plus 0.02 ml. _glac i a l acebc ac:i.d SL.....§. • .9-..f~ 10.0 ml. d .i ;:;t i1led 
water. Dilution ( l: 50) of thi s initial stock in De .ra :ton 1 s 
perfusate (1 x 10- 4 M/1. ) - - pH 7 . 0 . 
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APPENDIX D 
sules Nere removed f rom formalin and washed in rvnning water . 
Afte r \'tashing ( 10--15 minutes), the capsules were immersed 
successivel y in a series of alcohol ba ths : 
a ) 70% isopropanol for 3 hour s, 
b ) 75% isopropanol for 2 hours , 
c ) 80% i s opropanol for 2 hours , 
d ) 85Jb isopropanol for 2 hours , 
e ) 90(" jO i sopropanol for 2 hours , 
f') 95% isopropanol for 2 hours, 
g ) 99% isopropanol for 3 hours, 
h) 60 parts absolute i s opropanol plus 40 parts toluene 
for 2 hours , 
:L) 60 parts toluene plus 40 parts absolute isopropanol 
for 2 hours . 
Tissue ca.p.;ules were then placed in molten paraffin (Para-
plast )1 -·- ti'ro changes of' two hours duration each in a 
vacuum oven a t 56- 58°C. The tissues were then removed from 
the capsul es , embedded in a molten paraff in block , cooled 
to hardening in a refrigerator for one hour . Chilled , 
1 Bioloid Para ffin Embedding Compound V/1 - 85210 (M.P. 53-5.5°C ) 
Will Scientific , Inc . , Rochester , N.Y . 
embedded ti ssues were sectioned by a sliding microtome . 
Cut sections (approx i mat e l y 5 mi c rons th i ck) were f loa t ed 
on a si l icatc/an~onia solut ion , placed on microscope s l ides , 
a ir dried nnd stained . 
r epresents a sepa r ate vessel or s t age i n the proces s . The 
slides were placed. i n stainl ess s t eel carr ier s and sub-
j ccted succes sively t o: 
a ) xyl ol -- t en minutes , 
b) absolute i sopropanol - t en minutes , 
c ) a bsolute i s opr opanol - t en minutes , 
<1) rtn~e in cold water -·- 3 to 4 dips , 
c ) ~1allory 1 s (hematoxylin ) - five Jn i:~ute s , 
f ) rinse in changes of cold vrater until r inse wC!.tc r 
i s c l ear , 
g ) decolor i z ing acid solut ion -- ~ip, 
h) rinse i n cold water -- J to 4 d ips , 
i ) neutralizing ammonia solut ion 1% -- di p , 
j ) r i nse i n cold wa t er -- J to 4 dips , 
k ) eosin stain - - two minutes ~ 
1 ) clrain on abs orbant paper , 
m) absol ute ethanol -- dip , 
n ) dra in on abs or bant pape r , 
o ) a bs olute ethanol -- dip , 
p ) dra in on a bsorbant paper , 
q ) a bs olute e thanol - - dip, 
r· ) dr ain on absorbant paper , 
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s ) creosote/xylol ( .50/50) -- dip , 
t) drain on abs orbant paper, 
n) xyl ol dlp , 
v) drain on absorbant paper , 
vl) xylol dip , 
x ) clr·a in on absorbant paper, 
y) xylol dip, 
z) drain on absorbant paper and replace in fresh 
xylol until ready to coverslip. 
Stained tls sue slides were covers l ippcd using Permount..§ 
while still \'Tet with xylol and allOi•red to a ir dry for 
24 hours. 
-----· 
~ F'isher S . t·r · C F j I N J , c1en 1 J.c o, , a .r .. m·Tn, . • 
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APPENDIX E 
FORNULAS FOR SOLUTIONS AND STAINS USED IN TISSUE PHOCESSING 
----·,---.:...--··--~--·---·---·-----·- .. ----------------------
Formaldehyde 37-40% . • . • .• • • 100.00 ml. 
Sodium ace t a te . . . . •• . •. . , 20.00 Gm . 
Distilled wa ter • ••• •• •• • • 900 , 00 ml. 
Hcl 37/"o' , • • • • • 1 00 l ' • • • • • • • • J . • m. • 
Ethyl alcohol 70% . • • . • • . . • 99 . 00 ml. 
3 . ~gdi vm silicate floa tl.ng soltJ.ti..Qn . ~·-· 
Sodium silicate . • • .. . . • • . 80 . 00 
Ammoni a 28;~ • • • • • • • • • • • • 200 , 00 




r he worl{ing solutions were prep2r ed fr>om the above stor.k 
solut-ion: 2.5 to-30 ml. of stock solution .fL.§. , _gg ll.i s t iJ. l .ecl 
water 1000 ml. The paraffin- embedded sections were floated 
on this solution kept at 4_5°C by means of a water bath; 
wri nkles were removed with an ar t:i.s t ' s fine- bristl e brush 
and placed on mi croscope sl i des . Embedded tissue sec tion s 
affixed to glass s lides were a ir-dryed and stor ed at room 
t emperature unti l ready t o stain. 
Al( NHL~ ) (S04) 2 ..••...• . • . 50 . 00 Hematoxylin • • .• • •• •• •••• 2. 50 
HgO ( red ) •. •••••••••••• 1. 25 
Absolute ethanol ••••••• • •• 25. 00 






1'he n l wn and wate r \1/ere c ombined. in a ?000 ml. flask and heat 
was used t o make a solution . The hematoxylin was d i ssolve d 
in the alcohol and added to the alum~water s olution. This 
mix:turo was brought t o a boil, removed from the heat and the 
HgO aclded . The fl t?.sk was immediately covered with a beaker. 
A small portion of ethanol \'>'"as used to rinse dovm the ne cl( 
of the f Jask t o remove any HgO that remained. Af ter stirrl:ng , 
the product was cooled in a \·rater bath and fi l tered. 
Eosin powde r . . . . . • . • . . . 
Distilled water . • • . • . . . • 
Absolute ethanol . . . • • • • • 









'l'he dye was d .. i. s sol ved in vmt er , the a lcol-;ol was then addecl 1 
followed by the acetic ac.i.d~ 
Gi emsa dye . 
Glycerin . . 
. . . . . . . . . . . 0 . 50 Gm. 33.00 ml. 
These were heated at 60°C for 1! hours, and 33 . 0 ml. methanol 
was aclded. 
For staining blood: 
One drop of the concentrated d.ye mixture prepare d above. \'las 
d iluted \ITt t h :t .• 0 ml. di s till ed wate r buffered. to pH '1 . 0 . With 
this, the blood smear was stained for 10 to 20 minutes , rinsed 
in buffe r ed distilled water , and blotted dry on absorbant paper. 
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